Focus on increasing throughput of processes has favoured poorer models with lower chances of success
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say.
They say drug discovery should focus on ‘validity’ – how well the results of experiments predict results in sick people. Instead, it has focused on methods that are easy to industrialize or methods that are academically fashionable.
In a report published in the journal PLOS ONE, Jack Scannell, from Oxford University’s Centre for the Advancement of Sustainable Medical Innovation, and consultant Jim Bosley approach drug discovery using mathematical tools that are used by economists to study decision making. They show that the chance of discovering an effective drug is surprisingly sensitive to the validity of the experimental methods. Small changes in validity can have a bigger effect than running 10 or even 100 times more experiments.
They argue that productivity has declined because the most predictive methods lead to the discovery of good drugs, and research in those areas stops (e.g., stomach ulcers). This leaves scientists working on as-yet-untreated diseases using less predictive discovery methods (e.g., Alzheimer’s). They also suggest that changing industrial and scientific fashions have contributed to the problem.
The result: Methods have become less predictive over time, worse decisions have been made, and the cost of discovery has gone up.
Drug approvals have increased since 2012. The researchers say that this is likely down to the rising use of genetic information which improves the validity of the methods to discover treatments for rare diseases, though less so for common diseases.
Dr Jack Scannell said: ‘There is a nasty puzzle at the heart of modern biomedical research. On one hand, the technologies that people think are important have become hundreds, thousands, or even billions of times cheaper. On the other hand, it costs nearly 100 times more to bring a drug to market today than it did in 1950. New drugs can be very expensive, yet the industry is closing labs and firing scientists. Our work goes some way towards explaining the puzzle. Governments, companies, and charities should focus on identifying and funding predictive methods, even if they don’t match current scientific fashion.’
The Latest on: Drug development crisis
via Google News
The Latest on: Drug development crisis
- Medical professionals worry about lupus drug supply amid COVID-19 pandemicon March 23, 2020 at 10:25 am
OKLAHOMA CITY (KFOR) – While many people are hopeful that a known drug might be an effective treatment for novel coronavirus, health officials say it has also created a potential crisis for patients ...
- Fact check on President Trump saying he always knew the coronavirus was pandemicon March 23, 2020 at 9:43 am
Trump's statements came in a week of inflated expectations by him about an end game to the coronavirus crisis. He suggested that a drug to treat COVID-19 was at hand and that automakers ... TRUMP: ...
- As Covid-19 spreads, disruptions to clinical trial and drug development accelerateon March 23, 2020 at 6:21 am
The scope of the clinical trial delays and suspension — like just about everything touched by this expanding crisis — is hard to quantify ... The downstream impact for patients and the drug industry ...
- Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisison March 23, 2020 at 5:45 am
drug makers large and small have scrambled to advance their best ideas for thwarting a pandemic. The crisis has catalyzed the development of novel vaccines across the biotech industry, both by ...
- COVID-19 crisis: Businesses, governments and nonprofits adapt to uncertain timeson March 22, 2020 at 1:00 am
On the drug store side of Discount Drug Mart, Jason Briscoe, director of pharmacy operations, said that "every facet of the operations has been intensified in this crisis, from phone calls with ...
- “EVERYONE IS COUGHING.” FEAR AND ROVING DURING THE CORONAVIRUS CRISIS.on March 21, 2020 at 9:09 pm
He is one of the 18,471 homeless people who, according to a 2019 report from the US Department of Housing and Urban Development (HUD), reside in Massachusetts. Josué has been on the streets for seven ...
- NH to receive $28.1 million in federal funds to fight opioid, meth, cocaine crisis in 2020on March 21, 2020 at 2:55 pm
New Hampshire will receive $28.1 million in federal funding in 2020 to continue its efforts to combat the substance abuse crisis, Sens. Jeanne Shaheen and Maggie Hassan announced Friday.
- Fact-checking Donald Trump on drug treatments for COVID-19on March 21, 2020 at 10:52 am
That’s President Donald Trump, inflating expectations about an end game to the coronavirus crisis with his positive spin on a disease that is spreading with no federally approved drug treatments, no ...
- Might The Experimental Drug Remdesivir Work Against COVID-19?on March 21, 2020 at 4:19 am
“That’s typical of an epidemic or crisis like this,” says Ken Kaitin, who directs the Tufts Center for the Study of Drug Development. “Before [companies] start developing brand new drugs and new ...
- A way forward for fighting the drug crisison March 14, 2020 at 11:14 pm
A Santa Fe city task force set up to address the problem of opioid addiction and other problems from drug or alcohol abuse has backed off from some of the more “outside the box” ideas it was ...
via Bing News